Donald J. Hamel

1.2k total citations
25 papers, 739 citations indexed

About

Donald J. Hamel is a scholar working on Infectious Diseases, Virology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Donald J. Hamel has authored 25 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 13 papers in Virology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Donald J. Hamel's work include HIV Research and Treatment (13 papers), HIV/AIDS Research and Interventions (13 papers) and HIV/AIDS drug development and treatment (8 papers). Donald J. Hamel is often cited by papers focused on HIV Research and Treatment (13 papers), HIV/AIDS Research and Interventions (13 papers) and HIV/AIDS drug development and treatment (8 papers). Donald J. Hamel collaborates with scholars based in United States, Nigeria and Senegal. Donald J. Hamel's co-authors include Souleymane Mboup, Phyllis J. Kanki, Aïssatou Guèye‐Ndiaye, Max Essex, Jean-Louis Sankalé, Richard Marlink, Ibou Thior, Tidiane Siby, Jean‐Louis Sankalé and Ibrahima Ndoye and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Virology and The Journal of Infectious Diseases.

In The Last Decade

Donald J. Hamel

23 papers receiving 721 citations

Peers

Countries citing papers authored by Donald J. Hamel

Since Specialization

Citations

This map shows the geographic impact of Donald J. Hamel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald J. Hamel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald J. Hamel more than expected).

Fields of papers citing papers by Donald J. Hamel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald J. Hamel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald J. Hamel. The network helps show where Donald J. Hamel may publish in the future.

Co-authorship network of co-authors of Donald J. Hamel

This figure shows the co-authorship network connecting the top 25 collaborators of Donald J. Hamel. A scholar is included among the top collaborators of Donald J. Hamel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald J. Hamel. Donald J. Hamel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pre-pandemic cross-reactive antibody and cellular responses against SARS-CoV-2 among female sex workers in Dakar, Senegal 2025 ·Frontiers in Public Health ·Bobby Brooke Herrera, Beth Chaplin, Souleymane Mboup, Adam Abdullahi, (unknown), (unknown), Sulaimon Akanmu, Charlotte A. Chang, Donald J. Hamel, Ravindra K. Gupta, Phyllis J. Kanki	1
2	Preexisting yellow fever virus and West Nile virus immunity and pregnancy outcomes in a Nigerian cohort with endemic orthoflavivirus exposure 2025 ·Emerging Microbes & Infections ·Tae‐Woo Kim, Bobby Brooke Herrera, Beth Chaplin, (unknown), (unknown), Atiene S. Sagay, Charlotte A. Chang, Donald J. Hamel, Wei‐Kung Wang, Phyllis J. Kanki	1
3	SARS-CoV-2 live virus culture and sample freeze-thaw stability 2024 ·Diagnostic Microbiology and Infectious Disease ·Phyllis J. Kanki, Donald J. Hamel, Stefan Riedel, Sanjucta Dutta, Annie Cheng, Charlotte A. Chang, Ramy Arnaout, James E. Kirby	2
4	Pretreatment and Acquired Drug Resistance in Children With Human Immunodeficiency Virus Type 1 in Jos, Nigeria 2024 ·Open Forum Infectious Diseases ·Augustine Ebonyi, (unknown), Holly Rawizza, (unknown), Beth Chaplin, Donald J. Hamel, Stephen Oguche, Oche Agbaji, Atiene S. Sagay, Phyllis Kanki, Godwin Imade	0
5	Arbovirus surveillance in pregnant women in north-central Nigeria, 2019–2022 2023 ·Journal of Clinical Virology ·(unknown), Charlotte A. Chang, Olukemi Ige, Atiene S. Sagay, Beth Chaplin, (unknown), Michael J. Paul, (unknown), Godwin Imade, (unknown), (unknown), Szu‐Chia Hsieh, Wei‐Kung Wang, Donald J. Hamel, Phyllis J. Kanki	5
6	High SARS-CoV-2 seroprevalence in Lagos, Nigeria with robust antibody and cellular immune responses 2023 ·SHILAP Revista de lepidopterología ·Sulaimon Akanmu, Bobby Brooke Herrera, Beth Chaplin, (unknown), Akin Osibogun, (unknown), Sarah John‐Olabode, Iorhen E. Akase, (unknown), Donald J. Hamel, Charlotte A. Chang, Phyllis J. Kanki	4
7	Chikungunya virus antepartum transmission and abnormal infant outcomes in a cohort of pregnant women in Nigeria 2023 ·International Journal of Infectious Diseases ·Atiene S. Sagay, Szu‐Chia Hsieh, (unknown), Charlotte A. Chang, (unknown), Olukemi Ige, (unknown), Beth Chaplin, Godwin Imade, (unknown), Michael J. Paul, Donald J. Hamel, Hideki Furuya, Ricardo Khouri, Viviane Boaventura, (unknown), Phyllis J. Kanki, Wei‐Kung Wang	8
8	Sars-Cov-2 antigen tests predict infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large sample cohort 2022 ·Clinical Microbiology and Infection ·James E. Kirby, Stefan Riedel, Sanjucta Dutta, Ramy Arnaout, Annie Cheng, (unknown), Donald J. Hamel, Charlotte A. Chang, Phyllis J. Kanki	32
9	A modified anthrax toxin-based enzyme-linked immunospot assay reveals robust T cell responses in symptomatic and asymptomatic Ebola virus exposed individuals 2018 ·PLoS neglected tropical diseases ·Bobby Brooke Herrera, Donald J. Hamel, (unknown), (unknown), Sulaimon Akanmu, Charlotte A. Chang, Philomena Eromon, Onikepe Folarin, Adeyemi T. Kayode, Christian Happi, Yichen Lu, Folasade Ogunsola, Phyllis J. Kanki	8
10	Building laboratory capacity to support HIV care in Nigeria: Harvard/APIN PEPFAR, 2004–2012 2015 ·SHILAP Revista de lepidopterología ·Donald J. Hamel, Jean-Louis Sankalé, (unknown), Abdoulaye Dieng Sarr, Beth Chaplin, (unknown), Seema Meloni, Prosper Okonkwo, Phyllis J. Kanki	13
11	Short Communication: Transmitted HIV Drug Resistance in Antiretroviral-Naive Pregnant Women in North Central Nigeria 2013 ·AIDS Research and Human Retroviruses ·Godwin Imade, Atiene S. Sagay, Beth Chaplin, (unknown), (unknown), (unknown), Donald J. Hamel, (unknown), Oche Agbaji, (unknown), Seema Meloni, Jean-Louis Sankalé, Prosper Okonkwo, Phyllis J. Kanki	21
12	The Level of APOBEC3G (hA3G)-Related G-to-A Mutations Does Not Correlate with Viral Load in HIV Type 1-Infected Individuals 2008 ·AIDS Research and Human Retroviruses ·Nzovu Ulenga, Abdoulaye Dieng Sarr, Donald J. Hamel, Jean-Louis Sankalé, Souleymane Mboup, Phyllis J. Kanki	32
13	Twenty Years of Prospective Molecular Epidemiology in Senegal: Changes in HIV Diversity 2007 ·AIDS Research and Human Retroviruses ·Donald J. Hamel, Jean-Louis Sankalé, Geoffrey Eisen, Seema Meloni, Christopher W. Mullins, Aïssatou Guèye‐Ndiaye, Souleymane Mboup, Phyllis J. Kanki	52
14	HIV Type 1 Circulating Recombinant Form CRF09_cpx from West Africa Combines Subtypes A, F, G, and May Share Ancestors with CRF02_AG and Z321 2004 ·AIDS Research and Human Retroviruses ·Francine E. McCutchan, (unknown), Souleymane Mboup, Bohye Kim, Sodsai Tovanabutra, Donald J. Hamel, Stephanie K. Brodine, Phyllis J. Kanki, Deborah L. Birx	19
15	Molecular evolution of human immunodeficiency virus type 1 subtype A in Senegal: 1988-1997. 2000 ·PubMed ·(unknown), Donald J. Hamel, (unknown), (unknown), (unknown), Aïssatou Guèye‐Ndiaye, Max Essex, (unknown), Phyllis J. Kanki	19
16	Interaction with Human Immunodeficiency Virus (HIV) Type 2 Predicts HIV Type 1 Genotype 2000 ·Virology ·Abdoulaye Dieng Sarr, Jean-Louis Sankalé, Donald J. Hamel, Karin Travers, Aïssatou Guèye‐Ndiaye, Max Essex, Souleymane Mboup, Phyllis Kanki	12
17	Relation between HIV-2 proviral load and CD4+ lymphocyte count differs in monotypic and dual HIV infections. 1999 ·PubMed ·A. Sarr, Stephen J. Popper, Ibou Thior, Donald J. Hamel, Jean‐Louis Sankalé, Tidiane Siby, Richard Marlink, Max Essex, Souleymane Mboup, Phyllis Kanki	19
18	Human Immunodeficiency Virus Type 1 Subtypes Differ in Disease Progression 1999 ·The Journal of Infectious Diseases ·Phyllis Kanki, Donald J. Hamel, Jean‐Louis Sankalé, Chung‐Cheng Hsieh, Ibou Thior, Françis Barin, (unknown), Aïssatou Guèye‐Ndiaye, (unknown), Monty Montano, Tidiane Siby, Richard Marlink, Ibrahima Ndoye, Max Essex, Souleymane Mboup	279
19	HIV-1 and HIV-2 dual infection 1998 ·AIDS ·Abdoulaye Dieng Sarr, Donald J. Hamel, Ibou Thior, Efi Kokkotou, Jean‐Louis Sankalé, Richard Marlink, (unknown), Max Essex, Tidiane Siby, Ibrahima Ndoye, Souleymane Mboup, Phyllis J. Kanki	47
20	Expression of HIV-1 in the cerebrospinal fluid detected by the polymerase chain reaction and its correlation with central nervous system disease 1991 ·AIDS ·(unknown), Robert F. Miller, Michael Harrison, Donald J. Hamel, Rodney S. Daniels, Richard S. Tedder	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact